VIBROCIL
2,5MG/ML+0,25MG/ML NAS SPR SOL 1X15ML
Announcement of launch, break or close-out of marketing of a medicinal product
Type of announcement | Effective date | Alternate medicines ? | Reason for interruption/cessation of marketing | Estimated renewal date |
---|---|---|---|---|
Resumption of marketing | 31.03.2022 | |||
Interruption of marketing | 01.02.2022 |
0218102 Lék v jiné lékové formě |
Commercial/marketing reasons | 31/03/2022 |
Placing on the market | 21.04.2020 |
All reports are available in the Overview.